Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study

Abstract Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is unclear. The aim of this study was to analyze prognostic factors for early...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kamila Resova, Lukas Knybel, Tereza Parackova, Marian Rybar, Karel Cwiertka, Jakub Cvek
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-04-01
Col·lecció:	Radiation Oncology
Matèries:	SBRT ES-NSCLC Overall survival
Accés en línia:	https://doi.org/10.1186/s13014-024-02439-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!